Risedronate prevents bone loss in breast cancer survivors: A two-year, randomized, double-blind, placebo-controlled clinical trial

被引：0
|
作者：
Greenspan, S. L. [1 ]
Vujevich, K. T. [1 ]
Bhattachary, R. [2 ]
Perera, S. [1 ]
Brufsky, A. [1 ]
Lembersky, B. C. [1 ]
Vogel, V. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Univ Kansas, Kansas City, KS USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1017
引用
收藏
页码：S6 / S6
页数：1
相关论文
共 50 条
  • [1] Risedronate prevents bone loss in breast cancer survivors: A 2-year, randomized, double-blind, placebo-controlled clinical trial
    Greenspan, Susan L.
    Brufsky, Adam
    Lembersky, Barry C.
    Bhattacharya, Rajib
    Vujevich, Karen T.
    Perera, Subashan
    Sereika, Susan M.
    Vogel, Victor G.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (16) : 2644 - 2652
  • [2] Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial
    Greenspan, Susan L.
    Bhattacharya, Rajib K.
    Sereika, Susan M.
    Brufsky, Adam
    Vogel, Victor G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (01): : 131 - 136
  • [3] Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study
    Delmas, PD
    Balena, R
    Confravreux, E
    Hardouin, C
    Hardy, P
    Bremond, A
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 955 - 962
  • [4] THIAZIDE REDUCES BONE LOSS - A RANDOMIZED DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    WASNICH, RD
    DAVIS, JW
    HE, YF
    PETROVICH, H
    ROSS, PD
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S123 - S123
  • [5] Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
    Hines, Stephanie L.
    Mincey, Betty Anne
    Sloan, Jeff A.
    Thomas, Sachdev P.
    Chottiner, Elaine
    Loprinzi, Charles L.
    Carlson, Mark D.
    Atherton, Pamela J.
    Salim, Muhammad
    Perez, Edith A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1047 - 1053
  • [6] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    Greenspan, S. L.
    Vujevich, K. T.
    Brufsky, A.
    Lembersky, B. C.
    van Londen, G. J.
    Jankowitz, R. C.
    Puhalla, S. L.
    Rastogi, P.
    Perera, S.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 (06) : 1857 - 1864
  • [7] Prevention of bone loss with risedronate in breast cancer survivors: a randomized, controlled clinical trial
    S. L. Greenspan
    K. T. Vujevich
    A. Brufsky
    B. C. Lembersky
    G. J. van Londen
    R. C. Jankowitz
    S. L. Puhalla
    P. Rastogi
    S. Perera
    Osteoporosis International, 2015, 26 : 1857 - 1864
  • [8] Zoledronic acid prevents bone loss after liver transplantation - A randomized, double-blind, placebo-controlled trial
    Crawford, BAL
    Kam, C
    Pavlovic, J
    Byth, K
    Handelsman, DJ
    Angus, PW
    McCaughan, GW
    ANNALS OF INTERNAL MEDICINE, 2006, 144 (04) : 239 - 248
  • [9] TWO-YEAR MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL ASSESSING THE EFFECT OF WEEKLY RISEDRONATE ON BONE MINERAL DENSITY IN ADULTS WITH CF
    Haworth, C. S.
    Sharples, L.
    Hughes, V
    Elkin, S. L.
    Hodson, M.
    Conway, S.
    Etherington, C.
    Elborn, J. S.
    Rendall, J.
    Wheaton, E.
    Kadri, E.
    Elliott, J.
    Hlaing, T.
    Barker, H.
    Compston, J.
    PEDIATRIC PULMONOLOGY, 2010, : 423 - 423
  • [10] Prevention of early postmenopausal bone loss by strontium ranelate: A randomised, two-year, double-blind, placebo-controlled trial.
    Reginster, JL
    Deroisy, R
    Tsouderos, Y
    Jupsin, I
    Roux, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S222 - S222
12345